Drug Trial Radar · NCT06926647
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
Last checked: Nov 19, 2026Latest source record: Apr 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
2,000
Planned (sponsor's estimate)
Start
May 1, 2025
Primary completion
Dec 15, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Beijing 302 HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 14, 2025
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 1 year, up to 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, prospective, real-world study. The study plans to include a total of 2000 patients who meet the inclusion and exclusion criteria, consisting of 1600 treatment-naive patients and 400 treatment-experienced patients. The effectiveness and safety of different treatment strategies will be evaluated in children aged 1-12 years with treatment-naive and treatment-experienced chronic hepatitis B (CHB) and chronic HBV infection.
Conditions
- HBV
- Chronic Hepatitis b
Interventions
Nucleos(t)ide AnaloguesDrug
Administer NAs \[LAM, ETV, TDF, TAF (TAF preferred for those aged 6 years and older)\] continuously for 48 weeks based on age.
Interferon alfaDrug
IFNα monotherapy for 48 weeks (select conventional IFNα for ages ≥1 and \<3 years, select PEG-IFNα-2b for ages ≥3 years)
NAs combined with IFNαDrug
Receive NAs combined with IFNα treatment for 48 weeks.
comparative observationOther
Blank control observation for 48 weeks.
drug withdrawal observationOther
This group is the drug withdrawal observation group, which will strictly monitor virological indicators and biochemical results, and will reinitiate antiviral treatment if necessary based on antiviral treatment standards and the willingness of the child (or family members)
Primary outcomes
What the sponsor says the trial is designed to measure.
- HBsAg seroconversion rateTime frame: Week 48,96
Locations
85 sites in 1 country. Site status is shown where the registry gives one.
Ankang Central Hospital
Ankang, China
Anyang Fifth People's Hospital
Anyang, China
Beihai People's Hospital
Beihai, China
301 Hospital
Beijing, China
Binzhou Medical University Affiliated Hospital
Binzhou, China
Changzhi Medical College Affiliated Peace Hospital
Changzhi, China
Changzhou Third People's Hospital
Changzhou, China
Chengdu Public Health Clinical Medical Center
Chengdu, China
West China Second Hospital, Sichuan University
Chengdu, China
The First Affiliated Hospital of Dalian Medical University
Dalian, China
Dongguan People's Hospital
Dongguan, China
Dongying People's Hospital
Dongying, China
Foshan First People's Hospital
Foshan, China
Southern Medical University Shunde Hospital
Foshan, China
Guangzhou Medical University Affiliated Women and Children's Medical Center
Guangzhou, China
The Third Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, China
Hainan Women and Children's Medical Center
Haikou, China
Handan Infectious Disease Hospital
Handan, China
The First Affiliated Hospital of Anhui Medical University
Hefei, China
Hepu County People's Hospital
Hepu, China
Shanxian Central Hospital
Heze, China
Jiangmen Traditional Chinese Medicine Hospital
Jiangmen, China
Lanzhou Second People's Hospital
Lanzhou, China
Tibet Autonomous Region Third People's Hospital
Lhasa, China
Liaocheng People's Hospital
Liaocheng, China
Linfen People's Hospital
Linfen, China
Linfen Third People's Hospital
Linfen, China
Liuzhou Workers' Hospital
Liuzhou, China
Longyan Second Hospital
Longyan, China
Luoyang Central Hospital
Luoyang, China
Southwest Medical University Affiliated Hospital
Luzhou, China
Jiangxi Children's Hospital
Nanchang, China
Nanchang Ninth Hospital
Nanchang, China
The First Affiliated Hospital of Nanchang University
Nanchang, China
The Second Affiliated Hospital of Nanchang University
Nanchang, China
Nanning Fourth People's Hospital
Nanning, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, China
Nanyang Central Hospital
Nanyang, China
Affiliated Hospital of Putian University
Putian, China
Showing 40 of 85 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.